NuCana plc

NuCana is a clinical-stage biopharmaceutical company focused on significantly improving survival outcomes for patients with cancer. We use our proprietary ProTide™ technology to transform some of the most widely prescribed chemotherapy agents, nucleoside analogs, into more effective and safer medicines.Our highly experienced management team has a successful track record of building global, integrated biopharmaceutical companies and bringing life-saving oncology therapeutics to patients.


Bank Name NuCana plc
Stock Exchange NASDAQ
Symbol NCNA
Sector Healthcare
Industry Major Pharmaceuticals
Country United States
World Region Amarica
Chairman Prof. Christopher B. Wood
CEO Mr. Hugh S. Griffith
Employees 20
Registered Year 1997